Share on:

PGY-2 Pharmacy Residency in Oncology at Mayo Clinic Hospital — Rochester

PGY-2 Pharmacy Residents in Oncology

Developing the future oncology specialist

After the 12-month PGY-2 Pharmacy Residency in Oncology at Mayo Clinic Hospital — Rochester, you will be a proficient independent practitioner capable of providing advanced pharmaceutical care to oncology patients.

The program provides the high-quality didactic and clinical experiences needed to create a well-rounded, fully competent oncology pharmacist. As a PGY-2 oncology resident, you will:

  • Develop expertise, knowledge and skills in oncology therapies
  • Contribute to an interdisciplinary health care team offering patient-specific therapeutic interventions to treat, cure, rehabilitate, and alleviate medical conditions and diseases unique to cancer patients
  • Enhance your skills in conducting clinical research
  • Strengthen your communication skills by presenting formal and informal lectures, writing a professional manuscript, and leading interdisciplinary discussions

The PGY-2 oncology residency provides opportunities for advanced training in all areas related to cancer. During each rotation, you will work closely with your preceptor, highly qualified pharmacists, oncology physicians and other allied health care professionals.

Program history

The PGY-2 Pharmacy Residency in Oncology at Mayo Clinic Hospital — Rochester was accredited by the American Society of Health-System Pharmacists (ASHP) in 2003 and has produced respected clinicians who practice across the U.S. The program was recently reaccredited by ASHP for the maximum allowable term.

The residency program is continuously evaluated for improvement opportunities to ensure graduates make a seamless transition into clinical practice. One candidate a year is selected on a competitive basis.

Dedicated preceptors

Preceptors for the PGY-2 oncology residency provide direct patient care in virtually every specialty area and are actively involved in resident teaching and other scholarly activities. The preceptors come from diverse backgrounds and share numerous years of experience, clinical knowledge and research interests. You will have direct access to preceptors and mentors to optimize the learning experience.

More than 70 pharmacists at Mayo Clinic are certified by the Board of Pharmacy Specialties in various practice areas. All residency program preceptors meet the qualifications outlined by the ASHP.


Mayo Clinic Cancer Center is a National Cancer Institute-designated comprehensive cancer center with an international presence. More than 135,000 people receive cancer treatment at Mayo Clinic each year, making it one of the largest cancer treatment facilities in the nation.

Hundreds of clinical trials led by Mayo Clinic physicians and scientists are available for patients, including trials through the Alliance for Clinical Trials in Oncology, Phase I Program, Phase II Consortium and Cancer Prevention Network.

Additional trials are also available through cooperative research affiliations and collaborations with the National Cancer Institute and other clinical trial groups. Training for this residency is primarily conducted at Mayo Clinic Hospital — Rochester, though you may have rotations at Mayo Clinic's outpatient complex.

  • Oct 3, 2014
  • ART544613